Delivery Order SPE2DB25D3108-SPE2DB25FPDNX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,614.48 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price contract involves no set-aside designation and represents a competitive award to the major pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Premarin 0.625 mg tablets (100-count units) with a contract ceiling value of $1,490.37. This firm fixed-price delivery order, which is expected to be completed by August 4, 2025, represents a non-competitive set-aside arrangement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on July 25, 2025, to supply 1,000 tablets of Premarin 0.625 mg at a fixed price of $3,251.40, with completion scheduled for July 28, 2025. This non-set-aside, competitively awarded contract represents a routine pharmaceutical procurement supporting federal medical supply needs. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,554.64 by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Premarin 0.3 mg tablets (100-count units). The contract carries a firm fixed price structure with no set-aside designation and an ultimate completion date of July 31, 2025. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Premarin 0.3 mg tablets (100-count units) with a ceiling value of $4,722.10. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract is scheduled for ultimate completion by July 24, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,436.56 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100 count) on July 28, 2025. This firm fixed-price delivery order, designated as contract 4568902309, is scheduled for completion by July 29, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation and represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $8,600.44 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.625 mg on July 25, 2025, with an ultimate completion date of July 28, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award is issued under a larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of 1,000 tablets of Premarin 0.625 mg, a hormone replacement therapy medication. This $2,621.00 firm fixed-price delivery order, with performance in Park Ridge, Illinois, represents a non-competitive award under an existing contract vehicle. The delivery is scheduled for completion by August 11, 2025. This delivery order falls under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,808.85 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Premarin, a hormone replacement therapy medication, falls within the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,609.28 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.3 mg on July 24, 2025. The contract employs firm fixed price pricing with no set-aside designation, indicating competitive award. Performance is scheduled for completion by July 25, 2025, with work to be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Premarin is a conjugated estrogen hormone replacement therapy...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPDNXDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Premarin 0.625 mg tablets (100 count) under a firm fixed-price contract structure. This non-set-aside award carries a ceiling value of $1,905.17 and has an ultimate completion date of August 8, 2025. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order represents a discrete fulfillment action issued against a larger indefinite delivery vehicle that supports federal pharmaceutical procurement. This award is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive global pharmaceutical support agreement running through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a broad range of medications and medical supplies to military and veteran healthcare systems. The firm's substantial IDC vehicle enables flexible fulfillment of diverse pharmaceutical needs across multiple therapeutic domains, with delivery orders consistently structured as firm fixed-price transactions to support Defense Health Agency operations and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/7/25 |